Trican Well Service: Consensus Price Target Rises To $3.26

On July 27, Trican Well Service (TSX: TCW) reported their second-quarter financials. The company reported revenues of $93.7 million and a gross loss of only $0.2 million. The company’s adjusted EBITDA came in at $14.2 million, while the firm also reported $58.9 million in cash and cash equivalents for the period ending June 30.

All throughout July, analysts have been raising their 12-month price target on the company. This has brought Trican’s 12-month consensus price target to C$3.26, up from $2.67 at the end of June. The street high comes from ATB Capital with a C$3.50 price target, while the lowest comes in at $2.75 from TD. Out of the 10 analysts covering Trican, 1 analyst has a strong buy rating, 5 have buy ratings and 4 have hold ratings.

BMO raised their 12-month price target on Trican to C$3.50 from $3.25 and reiterated their Outperform rating saying that the results were impressive. Specifically, Trican’s $14 million in adjusted EBITDA was more than triple BMO’s $4 million estimates, while revenues nearly tripled year over year.

BMO says that cash is king and that Trican has almost $60 million in cash, “which should allow the company to pursue additional awards, particularly as customers look for upgraded equipment.”

Below you can see BMO’s updated third quarter, 2021, and 2022 estimates. They close the note by commenting, “Trican remains our preferred pressure pumping name in Canada, particularly given its high spec fleet and strong balance sheet.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Discovery at Luis Hill Prompts Acceleration of Phase 2 Program for Questcorp

Related News

BMO: Alphabet’s Q1 Earnings Are “Largely Fine”

On Tuesday, Alphabet (NASDAQ: GOOGL) reported its first quarter financial results. The company announced revenues...

Sunday, May 1, 2022, 04:50:00 PM

Vireo Health: Canaccord Lowers Revenue Estimates, Reiterates Price Target

Vireo Health (CSE: VREO) reported its second-quarter financials’ on August 26th, indicating revenue for the...

Thursday, August 27, 2020, 05:30:27 PM

Salesforce: Analysts Maintain Ratings Following Slack Acquisition Announcement

On December 1st, Salesforce.com (NYSE: CRM) announced a definitive agreement to buy Slack (NYSE: WORK)...

Thursday, December 3, 2020, 02:31:00 PM

Canopy Growth: Canaccord Forecasts $119.2 Million In Q2 Net Revenues

This morning, Canaccord Genuity released their second-quarter earnings preview for Canopy Growth Corp (TSX: WEED)...

Friday, November 6, 2020, 02:58:00 PM

Endeavour Silver Beats BMO’s Production Estimates By 30%

Last week, Endeavour Silver Corp. (TSX: EDR) announced their third quarter production highlights. For the...

Thursday, October 14, 2021, 03:20:00 PM